How do you like your therapy area? Rare
The rare disease area has seen a steady increase in awareness, and in the number of drugs being developed. In this panel, we will discuss the unique challenges in developing treatments for rare diseases, and how we can overcome them.
RON JORTNER | Managing Director & Trustee | Masthead Biosciences & Cambridge Rare Disease Network
PATRICK SHORT | Co-founder and Chief Executive Officer | Sano Genetics
VANESSA LEMARIE | Lead, Rare Disease Initiative | Ada Health
STEVE ANDERSON | Chief Scientific Officer | Covance
NICK SIREAU | Chair and Chief Executive Officer | AKU Society
JOHN McDERMOTT | Executive Drug Development Consultant | Quotient Sciences